These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15228130)

  • 21. Gender as a clinically relevant outcome variable in acne: benefits of a fixed combination clindamycin phosphate (1.2%) and benzoyl peroxide (2.5%) aqueous gel.
    Harper JC
    J Drugs Dermatol; 2012 Dec; 11(12):1440-5. PubMed ID: 23377514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clindoxyl gel for the treatment of acne vulgaris.
    Tan JK
    Skin Therapy Lett; 2002 May; 7(5):1-2. PubMed ID: 12223978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Chu A; Goulden V; Ambroziak M
    Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study.
    Dréno B; Kaufmann R; Talarico S; Torres Lozada V; Rodríguez-Castellanos MA; Gómez-Flores M; De Maubeuge J; Berg M; Foley P; Sysa-Jedrzejowska A; Kerrouche N; Paliargues F; Bettoli V
    Br J Dermatol; 2011 Aug; 165(2):383-90. PubMed ID: 21495995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized, observer-blind, split-face study to compare the irritation potential of 2 topical acne formulations over a 14-day treatment period.
    Ting W
    Cutis; 2012 Aug; 90(2):91-6. PubMed ID: 22988653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients.
    Thiboutot D; Zaenglein A; Weiss J; Webster G; Calvarese B; Chen D
    J Am Acad Dermatol; 2008 Nov; 59(5):792-800. PubMed ID: 18805603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne.
    Gold LS; Tan J; Cruz-Santana A; Papp K; Poulin Y; Schlessinger J; Gidner J; Liu Y; Graeber M;
    Cutis; 2009 Aug; 84(2):110-6. PubMed ID: 19746769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of a fixed combination of clindamycin phosphate 1.2%-benzoyl peroxide 2.5% aqueous gel on health-related quality of life in moderate to severe acne vulgaris.
    Webster G; Thiboutot DM; Chen DM; Merikle E
    Cutis; 2010 Nov; 86(5):263-7. PubMed ID: 21214129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [1 percent clindamycin phosphate solution versus 5 percent benzoyl peroxide gel in papulopustular acne].
    Schmidt JB; Neumann R; Fanta D; Raab W
    Z Hautkr; 1988 May; 63(5):374-6. PubMed ID: 2970159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of the addition of salicylic acid to clindamycin and benzoyl peroxide combination for acne vulgaris.
    Akarsu S; Fetil E; Yücel F; Gül E; Güneş AT
    J Dermatol; 2012 May; 39(5):433-8. PubMed ID: 22035285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The BEST study: evaluating efficacy by selected demographic subsets.
    Fernandez-Obregon A; Davis MW
    Cutis; 2003 Feb; 71(2 Suppl):18-26. PubMed ID: 12630671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks.
    Chang AL; Alora-Palli M; Lima XT; Chang TC; Cheng C; Chung CM; Amir O; Kimball AB
    J Drugs Dermatol; 2012 Mar; 11(3):333-9. PubMed ID: 22395584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical experience results with clindamycin 1% benzoyl peroxide 5% gel (Duac) as monotherapy and in combination.
    Bikowski JB
    J Drugs Dermatol; 2005; 4(2):164-71. PubMed ID: 15776773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overall results of the BEST study following treatment of patients with mild to moderate acne.
    Weiss J; Shavin J; Davis MW
    Cutis; 2003 Feb; 71(2 Suppl):10-7. PubMed ID: 12630670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of recalcitrant folliculitis barbae and pseudofolliculitis barbae with photodynamic therapy.
    Diernaes JE; Bygum A
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):651-3. PubMed ID: 24284123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study.
    Guerra-Tapia A
    J Drugs Dermatol; 2012 Jun; 11(6):714-22. PubMed ID: 22648218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
    Richter JR; Förström LR; Kiistala UO; Jung EG
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study design and selection criteria in the BEST study.
    Rist T; Davis MW
    Cutis; 2003 Feb; 71(2 Suppl):5-9. PubMed ID: 12630669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of chloroxylenol 0.5% plus salicylic acid 2% cream and benzoyl peroxide 5% gel in the treatment of acne vulgaris: a randomized double-blind study.
    Boutli F; Zioga M; Koussidou T; Ioannides D; Mourellou O
    Drugs Exp Clin Res; 2003; 29(3):101-5. PubMed ID: 14708455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
    Draelos ZD; Potts A; Alió Saenz AB;
    Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.